LakeShore Biopharma Co Ltd (LSB)
2.71
-0.39
(-12.58%)
USD |
NASDAQ |
Nov 14, 16:00
2.71
0.00 (0.00%)
After-Hours: 20:00
LakeShore Biopharma Shareholders Equity (Quarterly): 76.35M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 76.35M |
| June 30, 2023 | 91.09M |
| Date | Value |
|---|---|
| September 30, 2022 | -133.41M |
| March 31, 2022 | -109.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-133.41M
Minimum
Sep 2022
91.09M
Maximum
Jun 2023
-18.98M
Average
-16.79M
Median
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.649B |
| CASI Pharmaceuticals Inc | 9.021M |
| Zai Lab Ltd | 704.18M |
| China SXT Pharmaceuticals Inc | 13.93M |
| Adagene Inc | 56.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 220.84M |
| Total Liabilities (Quarterly) | 144.48M |